Cargando…

Population pharmacokinetics of voriconazole and initial dosage optimization in patients with talaromycosis

The high variability and unpredictability of the plasma concentration of voriconazole (VRC) pose a major challenge for clinical administration. The aim of this study was to develop a population pharmacokinetics (PPK) model of VRC and identify the factors influencing VRC PPK in patients with talaromy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Zhiwen, Wei, Yinyi, Huang, Weie, Li, Bingkun, Zhou, Siru, Liao, Liuwei, Li, Tiantian, Liang, Tianwei, Yu, Xiaoshu, Li, Xiuying, Zhou, Changjing, Cao, Cunwei, Liu, TaoTao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549404/ https://www.ncbi.nlm.nih.gov/pubmed/36225581 http://dx.doi.org/10.3389/fphar.2022.982981

Ejemplares similares

P403 Metagenomic sequencing as an effective diagnostic tool for Talaromycosis in HIV-negative patients: A retrospective study
por: Liang, Tianwei, et al.
Publicado: (2022)

Population pharmacokinetics of mycophenolate mofetil in pediatric patients early after liver transplantation
por: Wei, Yinyi, et al.
Publicado: (2022)

A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model
por: Wang, Taotao, et al.
Publicado: (2018)

S2.2c Talaromycosis in HIV-negative patients: challenges and counter-measures
por: Cao, Cunwei
Publicado: (2022)

Predicting the Outcome of Voriconazole Individualized Medication Using Integrated Pharmacokinetic/Pharmacodynamic Model
por: Yang, Ping, et al.
Publicado: (2021)

Population Pharmacokinetics of Polymyxin B and Dosage Optimization in Renal Transplant Patients
por: Li, Ying, et al.
Publicado: (2021)

Application of a Physiologically Based Pharmacokinetic Model to Characterize Time-dependent Metabolism of Voriconazole in Children and Support Dose Optimization
por: Zhang, Yahui, et al.
Publicado: (2021)

Efficacy and Safety of Voriconazole Versus Amphotericin B Deoxycholate Induction Treatment for HIV-Associated Talaromycosis: A Prospective Multicenter Cohort Study in China
por: Zhou, Yihong, et al.
Publicado: (2022)

Population Pharmacokinetics and Dosage Optimization of Teicoplanin in Children With Different Renal Functions
por: Gao, Liuliu, et al.
Publicado: (2020)

Population Pharmacokinetics of Vancomycin in Chinese ICU Neonates: Initial Dosage Recommendations
por: Li, Zhi-ling, et al.
Publicado: (2018)

Application of Population Pharmacokinetic Analysis to Characterize CYP2C19 Mediated Metabolic Mechanism of Voriconazole and Support Dose Optimization
por: Li, SiChan, et al.
Publicado: (2022)

The delayed clearance of Talaromyces marneffei in blood culture may be associated with higher MIC of voriconazole after antifungal therapy among AIDS patients with talaromycosis
por: Guo, Pengle, et al.
Publicado: (2023)

Inflammation Affects Liver Function and the Metabolism of Voriconazole to Voriconazole-N-Oxide in Adult and Elderly Patients
por: Liang, Zaiming, et al.
Publicado: (2022)

Factors influencing plasma concentration of voriconazole and voriconazole- N-oxide in younger adult and elderly patients
por: Cheng, Lin, et al.
Publicado: (2023)

Effects of Voriconazole on the Pharmacokinetics of Vonoprazan in Rats
por: Shen, Jiquan, et al.
Publicado: (2020)

Population pharmacokinetics of intravenous colistin sulfate and dosage optimization in critically ill patients
por: Xie, Yue-liang, et al.
Publicado: (2022)

Effects of Dosage, Comorbidities, and Food on Isoniazid Pharmacokinetics in Peruvian Tuberculosis Patients
por: Requena-Méndez, Ana, et al.
Publicado: (2014)

1566. Population Pharmacokinetics of Voriconazole: Serum Albumin Status as a Novel Marker of Clearance and Dosage Optimization
por: Chantharit, Prawat, et al.
Publicado: (2019)

Pharmacokinetic interaction of voriconazole and clarithromycin in Pakistani healthy male volunteers: a single dose, randomized, crossover, open-label study
por: Mushtaq, Mehwish, et al.
Publicado: (2023)

Population Pharmacokinetics and Initial Dosage Optimization of Tacrolimus in Pediatric Hematopoietic Stem Cell Transplant Patients
por: Liu, Xiao-Lin, et al.
Publicado: (2022)

Advances in diagnosis and treatment of talaromycosis in patients with AIDS
por: Guo, Pengle, et al.
Publicado: (2022)

Prediction for optimal dosage of pazopanib under various clinical situations using physiologically based pharmacokinetic modeling
por: Wu, Chunnuan, et al.
Publicado: (2022)

Non-HIV talaromycosis: Radiological and clinical analysis
por: Li, Xinchun, et al.
Publicado: (2020)

Disseminated talaromycosis in an HIV-infected patient
por: Chang, Chee Yik, et al.
Publicado: (2021)

Impact of extracorporeal membrane oxygenation on voriconazole plasma concentrations: A retrospective study
por: Ye, Qinghua, et al.
Publicado: (2022)

Software for Dosage Individualization of Voriconazole: a Prospective Clinical Study
por: Hope, William, et al.
Publicado: (2019)

Contribution of Population Pharmacokinetics of Glycopeptides and Antifungals to Dosage Adaptation in Paediatric Onco-hematological Malignancies: A Review
por: Leroux, Stéphanie, et al.
Publicado: (2021)

Drug-related talaromycosis: A case report
por: Lu, Yongsheng, et al.
Publicado: (2020)

Case Report: Monitoring Vancomycin Concentrations and Pharmacokinetic Parameters in Continuous Veno-Venous Hemofiltration Patients to Guide Individualized Dosage Regimens: A Case Analysis
por: Chen, Jihui, et al.
Publicado: (2021)

Optimizing tylosin dosage for co-infection of Actinobacillus pleuropneumoniae and Pasteurella multocida in pigs using pharmacokinetic/pharmacodynamic modeling
por: Lee, Eon-Bee, et al.
Publicado: (2023)

Initial dosage optimisation of cyclosporine in Chinese paediatric patients undergoing allogeneic haematopoietic stem cell transplantation based on population pharmacokinetics: a retrospective study
por: Feng, Huanwen, et al.
Publicado: (2023)

Population Pharmacokinetics and Model-Based Dosing Optimization of Teicoplanin in Pediatric Patients
por: Zhang, Tao, et al.
Publicado: (2020)

The recommended dosage regimen for caspofungin in patients with higher body weight or hypoalbuminaemia will result in low exposure: Five years of data based on a population pharmacokinetic model and Monte-Carlo simulations
por: Yang, Qianting, et al.
Publicado: (2022)

Clinical Analysis of Intravenous and Oral Sequential Treatment With Voriconazole for Candida Central Nervous System Infection in Six Premature Infants
por: Zhu, Yingying, et al.
Publicado: (2021)

Talaromycosis in a Patient on Nintedanib for Interstitial Lung Disease
por: Madgula, Anantha Sriharsha, et al.
Publicado: (2020)

Pulmonary Talaromycosis: A Window into the Immunopathogenesis of an Endemic Mycosis
por: Narayanasamy, Shanti, et al.
Publicado: (2021)

An Overview of Diagnostic and Management Strategies for Talaromycosis, an Underrated Disease
por: Zaongo, Silvere D., et al.
Publicado: (2023)

Interactive Effects of Glucocorticoids and Cytochrome P450 Polymorphisms on the Plasma Trough Concentrations of Voriconazole
por: Jia, Su-jie, et al.
Publicado: (2021)

Clinical features of patients with talaromycosis marneffei and microbiological characteristics of the causative strains
por: Peng, Lei, et al.
Publicado: (2022)

Predicted Vancomycin Dosage Requirement in Patients With Hematological Malignancies and Dosage Dynamic Adjustment
por: Song, Xiangqing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s89u5d8lotiq2v10u0dfpu047e